These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6127792

  • 1. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
    Flaten O, Sand T, Myren J.
    Scand J Gastroenterol; 1982 Mar; 17(2):283-8. PubMed ID: 6127792
    [Abstract] [Full Text] [Related]

  • 2. Adrenergic modulation of gastric inhibitory polypeptide secretion in man.
    Salera M, Ebert R, Giacomoni P, Pironi L, Venturi S, Corinaldesi R, Miglioli M, Barbara L.
    Dig Dis Sci; 1982 Sep; 27(9):794-800. PubMed ID: 7049625
    [Abstract] [Full Text] [Related]

  • 3. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B, Hedner P, Lundquist I.
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [Abstract] [Full Text] [Related]

  • 4. Adrenergic modulation of the release of pancreatic polypeptide after intraduodenal and oral glucose in man.
    Flaten O, Myren J.
    Scand J Gastroenterol; 1981 Jan; 16(6):781-7. PubMed ID: 6275494
    [Abstract] [Full Text] [Related]

  • 5. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B, Lundquist I.
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [Abstract] [Full Text] [Related]

  • 8. The effects of xylitol on the secretion of insulin and gastric inhibitory polypeptide in man and rats.
    Salminen S, Salminen E, Marks V.
    Diabetologia; 1982 Jun; 22(6):480-2. PubMed ID: 7049804
    [Abstract] [Full Text] [Related]

  • 9. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M.
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [Abstract] [Full Text] [Related]

  • 10. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S, O'Dorisio TM, Crockett SE, Mekhjian HS.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [Abstract] [Full Text] [Related]

  • 11. Reduced beta-adrenoceptor sensitivity in the elderly.
    Vestal RE, Wood AJ, Shand DG.
    Clin Pharmacol Ther; 1979 Aug; 26(2):181-6. PubMed ID: 37014
    [Abstract] [Full Text] [Related]

  • 12. Effect of isoproterenol on the plasma C-peptide and insulin levels in humans.
    Górski J, Holm G, Krotkiewski M.
    Horm Res; 1989 Aug; 31(4):175-9. PubMed ID: 2571555
    [Abstract] [Full Text] [Related]

  • 13. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB, Lauritzen JB, Christensen KC.
    Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
    [Abstract] [Full Text] [Related]

  • 14. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man.
    Salera M, Pironi L, Giacomoni P, Venturi S, Capelli M, Miglioli M, Barbara L.
    Digestion; 1982 Mar; 24(2):126-32. PubMed ID: 6127273
    [Abstract] [Full Text] [Related]

  • 15. The effect of adrenoceptor blockade on the release of gastric inhibitory polypeptide after intraduodenal glucose in humans.
    Flaten O.
    Scand J Gastroenterol; 1981 Mar; 16(5):641-5. PubMed ID: 7323697
    [Abstract] [Full Text] [Related]

  • 16. The effect of oral galactose on GIP and insulin secretion in man.
    Morgan LM, Wright JW, Marks V.
    Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
    [Abstract] [Full Text] [Related]

  • 17. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
    Lauritsen KB, Moesgaard F, Nielsen ML, Jensen SL.
    Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107
    [Abstract] [Full Text] [Related]

  • 18. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
    Ebert R, Creutzfeldt W.
    Diabetologia; 1980 Sep; 19(3):198-204. PubMed ID: 6997121
    [Abstract] [Full Text] [Related]

  • 19. Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7-36) amide-induced insulin release in the rat.
    Ikeda T, Ochi H, Ohtani I, Fujiyama K, Hoshino T, Tanaka Y, Takeuchi T, Mashiba H.
    Metabolism; 1993 Feb; 42(2):209-13. PubMed ID: 8386288
    [Abstract] [Full Text] [Related]

  • 20. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
    Ebert R, Illmer K, Creutzfeldt W.
    Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.